Launch week offerEnds in00h00m00s

annual Promonthly Pro

Michael Kleiman

Has grant

Research Assistant Professor

University of Miami

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Neuropsychology Neuropsychology professors in United States

About

Michael Kleiman is a Research Assistant Professor at the University of Miami, USA. His research focuses on cognitive health, particularly in the context of Alzheimer's disease and dementia, as evidenced by his recent publications on speech behavior in cognitive impairment, visual processing of audiovisual information, and the development of assessment tools for brain health. He is also involved in investigating the disparities in Alzheimer's disease risk among racial and ethnic minorities.

Recent Grants

Grant: Close

Development of a gaze- and speech-behavior based cognitive exam to assist in the detection of early-stage Alzheimer's disease and related disorders

Open Date: 2020-06-01

Close Date: 2022-05-01

Articles (17)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Deirdre M. O'Shea

Assistant Professor of Clinical

University of Miami Health System

UNITED STATES

View details

James Galvin

Professor

University of Miami School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Kleiman

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (17)

Associations between self-reported change in lifestyle behaviors and brain health: Findings from the Healthy Brain Initiative

Evaluating large language model performance and reliability in scoring picture description tasks for neuropsychological assessment

The Cognivue Amyloid Risk Measure (CARM): A Novel Method to Predict the Presence of Amyloid with Cognivue Clarity

Cognivue Clarity ® characterizes amyloid status and preclinical Alzheimer's disease in biomarker confirmed cohorts in the Bio-Hermes Study

The Brain Health Index: Integrating Vulnerability, Resilience, and Functioning Into a Unified Measure of Cognitive Health and Neurodegenerative Risk

Development and Validation of the DA3 Scale for Assessing Depression, Anxiety, and Apathy in Older Adults

The Healthy Brain 9 (HB9): A new instrument to characterize subjective cognitive decline, and detect anosognosia in mild cognitive impairment

High frequency post-pause word choices and task-dependent speech behavior characterize connected speech in individuals with mild cognitive impairment

Visual fixations during processing of time-compressed audiovisual presentations

The Healthy Brain Initiative (HBI): A prospective cohort study protocol

Hierarchical Two-Stage Cost-Sensitive Clinical Decision Support System for Screening Prodromal Alzheimer’s Disease and Related Dementias

Exploring Reasons for Differential Vulnerability and Alzheimer’s Disease Risk in Racial and Ethnic Minorities

The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders

Digital detection of dementia (D3): a study protocol for a pragmatic cluster-randomized trial examining the application of patient-reported outcomes and passive clinical decision support systems

The Vulnerability Index: A weighted measure of dementia and cognitive impairment risk

The Resilience Index: A Quantifiable Measure of Brain Health and Risk of Cognitive Impairment and Dementia

Using Optical Coherence Tomography to Screen for Cognitive Impairment and Dementia.

Collaborators (2)

Deirdre M. O'Shea

James Galvin

Make your next move.